Application of Different Biosensors for Cancer Detection
DOI:
https://doi.org/10.62051/mqpms008Keywords:
Cancer; Biomarkers; Biosensors; Detection.Abstract
Cancer is one of the main causes of death for humans while early detection can greatly lower cancer mortality and save lives. Therefore, reliable, cost-effective, and powerful technologies to detect the disease are needed. Cancer biomarkers are substances such as nucleic acids, enzymes, and metabolites, present in cancer clusters, tumours, or serum. While biosensors provide a quick, accurate, sensitive, uncomplicated, and economical method of diagnosing a particular cancer biomarker and is important to cancer detection and treatment, especially early diagnosis. Biosensors could be classified into three types: mass-based, electrochemical, or optical biosensors. With the development of science and technology and continuous research, more biosensors are designed for advanced technology, such as nanotechnology. The new and novel biosensors provide a powerful way for cancer detection. The objective of this research is to discuss the novel biosensors designed in recent years. In the future, more powerful biosensors will be designed and applied to cancer diagnosis and treatment.
Downloads
References
[1] Fitzgerald R C, Antoniou A C, Fruk L, et al. The future of early cancer detection. Nature medicine, 2022, 28(4): 666-677.
[2] Strimbu K, Tavel J A. What are biomarkers. Current Opinion in HIV and AIDS, 2010, 5(6): 463-466.
[3] Gundogdu A, Gazoglu G, Kahraman E, et al. Biosensors: Types, applications, and future advantages. Journal of Scientific Reports-A, 2023 (052): 457-481.
[4] Abati S, Bramati C, Bondi S, et al. Oral cancer and precancer: a narrative review on the relevance of early diagnosis. International journal of environmental research and public health, 2020, 17(24): 9160.
[5] Rebaudi F, De Rosa A, Greppi M, et al. A new method for oral cancer biomarkers detection with a non-invasive cyto-salivary sampling and rapid-highly sensitive ELISA immunoassay: a pilot study in humans. Frontiers in Immunology, 2023, 14: 1216107.
[6] Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 2024, 74(3): 229-263.
[7] Bose M, Singh S S, Ganesharaja S, et al. Development and Evaluation of p16 based Double Antibody Sandwich ELISA for Detection of Cervical Precancer and Cancer. Asian Pacific Journal of Cancer Prevention: APJCP, 2023, 24(7): 2337.
[8] Volkova L V, Pashov A I, Omelchuk N N. Cervical carcinoma: oncobiology and biomarkers. International journal of molecular sciences, 2021, 22(22): 12571.
[9] Mittal S, Saharia A, Ismail Y, et al. Spiral shaped photonic crystal fiber-based surface plasmon resonance biosensor for cancer cell detection. Photonics. MDPI, 2023, 10(3): 230.
[10] Mostufa S, Akib T B A, Rana M M, et al. Highly sensitive TiO2/Au/graphene layer-based surface plasmon resonance biosensor for cancer detection. Biosensors, 2022, 12(8): 603.
[11] Moisoiu V, Socaciu A, Stefancu A, et al. Breast cancer diagnosis by surface-enhanced Raman scattering (SERS) of urine. Applied Sciences, 2019, 9(4): 806.
[12] Avci E, Yilmaz H, Sahiner N, et al. Label-free surface enhanced raman spectroscopy for cancer detection. Cancers, 2022, 14(20): 5021.
[13] Anzar N, Hasan M R, Akram M, et al. Systematic and validated techniques for the detection of ovarian cancer emphasizing the electro-analytical approach. Process biochemistry, 2020, 94: 126-135.
[14] Hasan M R, Sharma P, Pilloton R, et al. Colorimetric biosensor for the naked-eye detection of ovarian cancer biomarker PDGF using citrate modified gold nanoparticles. Biosensors and Bioelectronics: X, 2022, 11: 100142.
[15] Miao X, Zhu Z, Jia H, et al. Colorimetric detection of cancer biomarker based on enzyme enrichment and pH sensing. Sensors and Actuators B: Chemical, 2020, 320: 128435.
[16] Muñoz-San Martín C, Pedrero M, Gamella M, et al. A novel peptide-based electrochemical biosensor for the determination of a metastasis-linked protease in pancreatic cancer cells. Analytical and Bioanalytical Chemistry, 2020, 412: 6177-6188.
[17] Zhang X, Yu Y, Shen J, et al. Design of organic/inorganic nanocomposites for ultrasensitive electrochemical detection of a cancer biomarker protein. Talanta, 2020, 212: 120794.
[18] Benson 3rd A B, Abrams T A, Ben-Josef E, et al. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. Journal of the National Comprehensive Cancer Network: JNCCN, 2009, 7(4): 350-391.
[19] Zhou L, Ji F, Zhang T, et al. A fluorescent aptasensor for sensitive detection of tumor marker based on the FRET of a sandwich structured QDs-AFP-AuNPs. Talanta, 2019, 197: 444-450.
[20] Xu S, Dong B, Zhou D, et al. based upconversion fluorescence resonance energy transfer biosensor for sensitive detection of multiple cancer biomarkers. Scientific Reports, 2016, 6(1): 23406.
Downloads
Published
Conference Proceedings Volume
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
